Silicon Laboratories was founded in 1996 and is headquartered in Austin, US

Silicon Laboratories has offices in Austin, Boston, Espoo, Budapest and in 15 other locations

Austin, US (HQ)

400 W Cesar Chavez St

High Wycombe, GB

Abbey Barn Ln Abbey Barn Cottage

Blackwater, GB

Meadows Business Park Station Approach

Gallarate, IT

36 Via Marsala

Budapest, HU

Graphisoft Park S épület 7 Záhony U.

Hong Kong, HK

66 Mody Rd

Hallbergmoos, DE

49 Ludwigstraße

Bures Sur Yvette, FR

8 Avenue Des Ulis

Shanghai, CN

Tian Lin Lu

Irvine, US

900 100 Spectrum Center Dr

Sunnyvale, US

940 Stewart Dr

Singapore, SG

6 Serangoon North Ave 5

Oslo, NO

118 Sandakerveien

Budapest, HU

7 Záhony U.

Espoo, FI

3 Bertel Jungin Aukio

Boston, US

4100 343 Congress St

Silicon Laboratories's revenue was reported to be $697.6 m in FY, 2016 which is a **8% increase** from the previous period.

Numbers are in $, USD

## Revenue (FY, 2016) | 697.6 m |

## Revenue growth (FY, 2015 - FY, 2016), % | 8% |

## Gross profit (FY, 2016) | 421.5 m |

## Gross profit margin (FY, 2016), % | 60% |

## Net income (FY, 2016) | 61.5 m |

## EBIT (FY, 2016) | 66.3 m |

## Market capitalization (26-May-2017) | 3.2 b |

## Closing share price (26-May-2017) | 73.8 |

## Cash (31-Dec-2016) | 141.1 m |

## EV | 3.1 b |

Silicon Laboratories's current market capitalization is $3.2 b.

Numbers are in $, USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Revenue | 580.1 m | 620.7 m | 644.8 m | 697.6 m |

## Revenue growth, % | 7% | 4% | 8% | |

## Cost of goods sold | 227.2 m | 242.2 m | 264.1 m | 276.1 m |

## Gross profit | 352.9 m | 378.6 m | 380.8 m | 421.5 m |

## Gross profit Margin, % | 61% | 61% | 59% | 60% |

## Operating expense total | 288.6 m | 327.1 m | 348.5 m | 355.2 m |

## EBIT | 64.3 m | 51.4 m | 32.2 m | 66.3 m |

## EBIT margin, % | 11% | 8% | 5% | 10% |

## Interest expense | 3.3 m | 3.2 m | 2.8 m | 2.6 m |

## Interest income | 853 k | 1 m | 730 k | 1.3 m |

## Pre tax profit | 62 m | 49 m | 30.3 m | 64.5 m |

## Income tax expense | 12.2 m | 11 m | 677 k | 3 m |

## Net Income | 49.8 m | 38 m | 29.6 m | 61.5 m |

Numbers are in $, USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Cash | 95.8 m | 141.7 m | 114.1 m | 141.1 m |

## Accounts Receivable | 72.1 m | 70.4 m | 73.6 m | 74.4 m |

## Inventories | 45.3 m | 52.6 m | 53.9 m | 59.6 m |

## Current Assets | 459.3 m | 528.5 m | 423.1 m | 490.9 m |

## PP&E | 132.4 m | 132.8 m | 131.1 m | 129.6 m |

## Goodwill | 228.8 m | 228.8 m | 272.7 m | 276.1 m |

## Total Assets | 991.2 m | 1 b | 1 b | 1.1 b |

## Accounts Payable | 22.1 m | 38.9 m | 42.1 m | 39.6 m |

## Total Debt | 95 m | 87.5 m | 77.5 m | 82.5 m |

## Current Liabilities | 109.1 m | 163.3 m | 142.3 m | 139.7 m |

## Total Liabilities | 252.6 m | 284.5 m | 250.3 m | 254.9 m |

## Additional Paid-in Capital | 48.6 m | 29.5 m | 13.9 m | 24.5 m |

## Retained Earnings | 690.6 m | 728.6 m | 747.7 m | 802 m |

## Total Equity | 738.6 m | 758.1 m | 761.1 m | 827 m |

## EPS | 0.9 | 0.7 | 1.5 | |

## Debt to Equity Ratio | 0.1 x | 0.1 x | 0.1 x | 0.1 x |

## Debt to Assets Ratio | 0.1 x | 0.1 x | 0.1 x | 0.1 x |

## Financial Leverage | 1.3 x | 1.4 x | 1.3 x | 1.3 x |

Numbers are in $, USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Net Income | 49.8 m | 38 m | 29.6 m | 61.5 m |

## Depreciation and Amortization | 13.5 m | 12.6 m | 12.5 m | 13.2 m |

## Accounts Receivable | 9 m | 1.8 m | 1.7 m | 46 k |

## Inventories | 5.6 m | (7.2 m) | 2.1 m | (6.1 m) |

## Accounts Payable | (4 m) | 11.5 m | 6.7 m | 263 k |

## Cash From Operating Activities | 120.2 m | 137.4 m | 105.4 m | 128.9 m |

## Purchases of PP&E | (10.5 m) | (11.2 m) | (11.3 m) | (10.9 m) |

## Cash From Investing Activities | (105.9 m) | (26.3 m) | (49.3 m) | (49.6 m) |

## Cash From Financing Activities | (23.9 m) | (65.2 m) | (83.8 m) | (52.3 m) |

## Interest Paid | 2.9 m | 3 m | 2.5 m | 2.2 m |

## Income Taxes Paid | 3.8 m | 11.6 m | 2.2 m | 11.2 m |

Numbers are in $, USD | Y, 2016 |
---|---|

## P/E Ratio | 50.2 |

## EV/EBIT | 46.8 x |

## EV/CFO | 24.1 x |

## Revenue/Employee | 623.4 k |

## Debt/Equity | 0.1 x |

## Debt/Assets | 0.1 x |

## Financial Leverage | 1.3 x |

Source: 127 public H-1B filings from Silicon Laboratories